QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online May 28, 2004
doi: 10.1242/10.1242/jcs.01133

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Castro, C. H. M. Articles by Civitelli, R. Search for Related Content PubMed PubMed Citation Articles by Castro, C. H. M. Articles by Civitelli, R. Social Bookmarking                         What's this?

Targeted expression of a dominant-negative N-cadherin in vivo delays peak bone mass and increases adipogenesis

Charlles H. M. Castro^1,3,*, Chan Soo Shin^1,4,*, Joseph P. Stains¹, Su-Li Cheng¹, Sharmin Sheikh¹, Gabriel Mbalaviele^1,5, Vera Lucia Szejnfeld³ and Roberto Civitelli^1,2,

¹ Division of Bone and Mineral Diseases, Department of Internal Medicine, Washington University School of Medicine, 216 S. Kingshighway Blvd, St Louis, MO 63110, USA
² Department of Cell Biology and Physiology, Washington University School of Medicine, 216 S. Kingshighway Blvd, St Louis, MO 63110, USA
³ Universidade Federal de São Paulo-Escola Paulista de Medicina, Rua Botucatu 740, São Paulo-SP, Brasil
⁴ Department of Internal Medicine, Seoul National University College of Medicine, 28 Yongon-Dong, Chongno-Gu, Seoul 110-774, Republic of Korea
⁵ Pfizer Incorporated, 700 Chesterfield Parkway West, Chesterfield, MO 63107, USA

Author for correspondence (e-mail: rcivitel{at}im.wustl.edu)

Accepted 2 February 2004

We studied the function of osteoblast cadherins in vivo by transgenic expression of a truncated N-cadherin with dominant-negative action, driven by an osteoblast-specific promoter (OG2-NcadC). During the first 3 months of life, bone mineral density was reduced, whereas percent body fat was increased in transgenic animals compared with wild-type littermates, with associated decreased bone formation rate and osteoblast number, but normal osteoclast number. Osteoblast differentiation was delayed in calvaria cells isolated from transgenic mice. Likewise, the number of osteoblast precursors in bone marrow stromal cells from OG2-NcadC mice was decreased compared with wild-type cultures, whereas the number of adipogenic precursors was increased. In vitro, a transcriptionally active ß-catenin mutant reversed the delay in osteoblast differentiation and the exuberant adipogenesis. Thus, in vivo disruption of cadherin function hinders osteoblast differentiation and favors, indirectly, bone marrow progenitor cell commitment to the alternative adipogenic lineage via interference with ß-catenin signaling. This results in decreased bone formation, delayed acquisition of peak bone mass and increased body fat.

Key words: Cell-cell adhesion, Mesenchymal differentiation, Cadherins, Adipogenesis, Transgenic mice

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				P. J. Marie N-Cadherin-Wnt Connections and the Control of Bone Formation IBMS BoneKEy, April 1, 2009; 6(4): 150 - 156. [Abstract] [Full Text] [PDF]

				E. Hay, E. Laplantine, V. Geoffroy, M. Frain, T. Kohler, R. Muller, and P. J. Marie N-Cadherin Interacts with Axin and LRP5 To Negatively Regulate Wnt/{beta}-Catenin Signaling, Osteoblast Function, and Bone Formation Mol. Cell. Biol., February 15, 2009; 29(4): 953 - 964. [Abstract] [Full Text] [PDF]

				S.-L. Cheng, J.-S. Shao, J. Cai, O. L. Sierra, and D. A. Towler Msx2 Exerts Bone Anabolism via Canonical Wnt Signaling J. Biol. Chem., July 18, 2008; 283(29): 20505 - 20522. [Abstract] [Full Text] [PDF]

				M. A. Mori, R. C. Araujo, F. C.G. Reis, D. G. Sgai, R. G. Fonseca, C. C. Barros, V. F. Merino, M. Passadore, A. M. Barbosa, B. Ferrari, et al. Kinin B1 Receptor Deficiency Leads to Leptin Hypersensitivity and Resistance to Obesity Diabetes, June 1, 2008; 57(6): 1491 - 1500. [Abstract] [Full Text] [PDF]

				S. Ramanadham, K. E. Yarasheski, M. J. Silva, M. Wohltmann, D. V. Novack, B. Christiansen, X. Tu, S. Zhang, X. Lei, and J. Turk Age-Related Changes in Bone Morphology Are Accelerated in Group VIA Phospholipase A2 (iPLA2{beta})-Null Mice Am. J. Pathol., April 1, 2008; 172(4): 868 - 881. [Abstract] [Full Text] [PDF]

				R. Dobrowolski, P. Sasse, J. W. Schrickel, M. Watkins, J.-S. Kim, M. Rackauskas, C. Troatz, A. Ghanem, K. Tiemann, J. Degen, et al. The conditional connexin43G138R mouse mutant represents a new model of hereditary oculodentodigital dysplasia in humans Hum. Mol. Genet., February 14, 2008; 17(4): 539 - 554. [Abstract] [Full Text] [PDF]

				J. Ma, M. Shi, J. Li, B. Chen, H. Wang, B. Li, J. Hu, Y. Cao, B. Fang, and R. C. Zhao Senescence-unrelated impediment of osteogenesis from Flk1+ bone marrow mesenchymal stem cells induced by total body irradiation and its contribution to long-term bone and hematopoietic injury Haematologica, July 1, 2007; 92(7): 889 - 896. [Abstract] [Full Text] [PDF]

				D. J. Chung, C. H. M. Castro, M. Watkins, J. P. Stains, M. Y. Chung, V. L. Szejnfeld, K. Willecke, M. Theis, and R. Civitelli Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin43 J. Cell Sci., October 15, 2006; 119(20): 4187 - 4198. [Abstract] [Full Text] [PDF]

				K.-i. Kim, H.-J. Cho, J.-Y. Hahn, T.-Y. Kim, K.-W. Park, B.-K. Koo, C. Soo Shin, C.-H. Kim, B.-H. Oh, M.-M. Lee, et al. {beta}-Catenin Overexpression Augments Angiogenesis and Skeletal Muscle Regeneration Through Dual Mechanism of Vascular Endothelial Growth Factor-Mediated Endothelial Cell Proliferation and Progenitor Cell Mobilization Arterioscler Thromb Vasc Biol, January 1, 2006; 26(1): 91 - 98. [Abstract] [Full Text] [PDF]